How do we bring back generic drug manufacturing to the United States in order to be less reliant on India, China? A National Academies of Science conference brings in some experts to try and answer that, including the chair of CPA Healthcare Committee.
WASHINGTON — The Coalition for a Prosperous America (CPA) today applauded two critical pieces of legislation reintroduced by Senator Elizabeth Warren (D-MA) that seek to
WASHINGTON — The Coalition for a Prosperous America (CPA) today criticized the Biden administration for undercutting a campaign promise to ensure that U.S. taxpayer dollars
A Senate hearing today looked back at our early response to the pandemic. A year later, what went right, what went wrong, and how to re-shore pharma now.
It’s time for Elizabeth Warren to re-introduce her pharmaceutical supply chain legislation.
Three members of Congress representing both parties are writing legislation to help domestic enterprises post-pandemic.
Healthcare panelist and Phlow CEO Eric Edwards on what needs to be done to make more pharmaceutical drugs here. Most of them are coming in from Europe, India and…increasingly…China.
By Kenneth Rapoza, CPA Industry Analyst The FDA hasn’t inspected nearly 1,000 overseas labs making drugs for the US market due to the pandemic. But
Rosemary Gibson chairs the healthcare committee of the Coalition for a Prosperous America. She is the author of “China Rx: Exposing the Risks of America’s
By Kenneth Rapoza, CPA Industry Analyst Score one for the local pharmaceutical industry. FDA’s essential medicine and critical inputs list gives domestic producers a a
